Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression and methylation profiling in primary AML cells treated with decitabine and cytarabine

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE40871 | GEO | 2012/12/18

SECONDARY ACCESSION(S): PRJNA175141

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Gene expression and methylation profiling in primary AML cells treated with decitabine and cytarabine

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2012-12-18 | E-GEOD-40871 | biostudies-arrayexpress

Gene expression profiling in primary AML cells treated with decitabine and cytarabine

2012-12-18 | GSE40442 | GEO

Gene expression profiling in primary AML cells treated with decitabine and cytarabine

Project description:Acute myeloid leukemia (AML), and other myeloid malignancies, are frequently treated with hypomethylating agents like decitabine. Alterations in the epigenome, induced by decitabine, are likely to result in gene expression changes. The effects of decitabine have not been systemically studied using primary AML samples. We cultured 18 different primary AML samples for 7 days, the last 3 days of which included 100 nM decitabine (DAC) or 100 nm cytarabine (AraC). We hypothesized that decitabine treatment would result in detectable and consistent gene expression changes. For comparison, we also analyzed mRNA from cells treated with DMSO control (mock) and mRNA from uncultured cells taken at the time of diagnosis.

2012-12-18 | E-GEOD-40442 | biostudies-arrayexpress

Expression profiling and methylation analysis of DNMT1 inhibitor treated AML cell lines

Project description:This SuperSeries is composed of the SubSeries listed below.

2021-06-30 | GSE135207 | GEO

Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia.

Project description: Not available

| S-EPMC3448258 | biostudies-literature

Single-Cell RNA-Seq Datasets of residual AML cells purifed from Patient Derived Xenograft bone marrow treated or not with venetoclax plus cytarabine

Project description:This SuperSeries is composed of the SubSeries listed below.

2021-06-26 | GSE178912 | GEO

U937 treated with decitabine, panobinostat and valproic acid

Project description:This SuperSeries is composed of the SubSeries listed below.

2016-05-12 | GSE81309 | GEO

Specific molecular signatures underlie response to decitabine in CMML

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2015-03-31 | E-GEOD-61163 | biostudies-arrayexpress

DNA methylation landscape in AML

Project description:This SuperSeries is composed of the SubSeries listed below.

2015-10-07 | GSE62303 | GEO

Transcriptional profile of AML xenografts treated with either PBS or a combination of decitabine and cytarabine

Project description:The Affymetrix Human Genome U133 Plus 2.0 Array was used to examine the Genome wide transcriptional changes which follow the treatment of AML xenografts with either PBS control or combination of decitabine (DAC) and cytarabine (Ara-C). Animals were treated with PBS, DAC alone, Ara-C alone, DAC and Ara-C combined (D+A), DAC followed by Ara-C (D/A) or Ara-C followed by DAC (A/D). PBS vs each drug combination

2013-03-06 | E-GEOD-44857 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data